Can Babies Be Born with Cancer?

Can babies be born with cancer?

For any parent, having a child with cancer is devastating. For the parents of Carrick Stafford Wood, it was even more so. Carrick was born with cancer, specifically acute myeloid leukemia (or AML). He spent the first six months of his life in the hospital before finally going home on Christmas Day. We spoke to Lisa Diller, MD, clinical director of Pediatric Oncology at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, about this rare scenario. Is it unusual for babies to be born with cancer? It’s unusual, but it can happen. The most common cancer in newborns is neuroblastoma – …

Continue reading

Collaborative Effort Helps Develop More Effective Treatment for Brain Tumors

The information used in diagnosing a brain tumor takes many forms. At Dana-Farber/Brigham and Women’s Cancer Center (DF/BWCC), patients’ brain tumor tissue undergoes a broad range of diagnostic tests: not only standard pathology exams in which tumor cells are viewed under a microscope, but also next-generation scans for mutated genes and misassembled chromosomes, as well as whole-genome searches for surplus or missing copies of genes. Such extensive testing helps pinpoint the exact type and characteristics of a particular tumor. The more specific the diagnosis, the more precise the therapy can be. But such a wealth of test results is only …

Continue reading

Important Terms Every Breast Cancer Patient Should Know

SOG_8566_13SMALL

After a breast cancer diagnosis, it can sometimes be hard to wrap one’s mind around all of the terminology used by doctors and nurses. In fact, a recent study from Dana-Farber Cancer Institute found a significant lack of knowledge among breast cancer patients about the basic characteristics of their disease, including how advanced it is (stage), the grade, and the subtype (e.g. whether it is hormone receptor-positive or HER2-positive). The study surveyed 500 women in the California Cancer Registry who had early-stage breast cancer. Between 56-58 percent of women knew the correct stage and receptor status of their tumor, and …

Continue reading

Why the President’s Precision Medicine Initiative Is Good for Cancer Research

4.25.14 GenomicsSmall

A boost in funding for research on genetic causes of cancer and “tailored” cancer treatments will be a major focus of the new Precision Medicine Initiative. President Barack Obama is requesting an increase of $215 million in the 2016 budget, to launch the effort “to bring us closer to curing diseases like cancer and diabetes – and to give all of us access to the personalized information we need to keep ourselves and our families healthier.” Of that total, $130 million is slated for the NIH for development of a voluntary national research cohort of a million or more volunteers, …

Continue reading

The Latest in Cervical Cancer Treatment, Research and Prevention

SMALL_AlexiLarissaWebchat

Although cervical cancer is relatively rare in the United States, approximately 11,000-12,000 women in the U.S. are diagnosed with the disease each year. Globally, that number grows to more than 500,000 diagnoses each year, making it the fourth most common women’s cancer worldwide. As January marks Cervical Cancer Awareness Month, the Susan F. Smith Center for Women’s Cancers at Dana-Farber hosted a live cervical cancer webchat with Ursula Matulonis, MD, medical director of the Gynecologic Oncology Program at the Susan F. Smith Center, medical oncologist Alexi Wright, MD, MPH, and radiation oncologist Larissa Lee, MD. The discussion included information about …

Continue reading

What to Expect for Cancer Prevention and Therapies in 2015

Dr. William Hahn

This post was originally published on Cancer Research Catalyst, the official blog of the American Association for Cancer Research (AACR).  Since the beginning of the “war on cancer” in the 1970s, we have made consistent progress against cancer aided by paradigm-shifting technological advances. Last year, we witnessed significant developments being made on several different fronts. Proof of this is the approval by the U.S. Food and Drug Administration (FDA) of eight cancer drugs, including a few milestone “first-of-their-kind” drugs encompassing immunotherapies and targeted therapies, and a nine-valent vaccine that can prevent infections that cause cervical cancer. The substantial gains we have made …

Continue reading

Precision Medicine and the Future of Cancer Treatment

SOG_1870_14

Precision medicine is rapidly changing the way cancer is studied and treated today. With new information about genetic and molecular characteristics in tumors, doctors are finding more effective and less toxic ways to fight the disease. “Precision medicine is seeing the monster of cancer clearly for the first time in a way that we can pinpoint weaknesses and then go into our arsenal and try new drugs to attack those weaknesses,” says Levi Garraway, MD, PhD, director of the Joint Center for Cancer Precision Medicine at Dana-Farber. Garraway recently discussed the evolving field of precision medicine in a Science, Innovation, …

Continue reading

Does Pregnancy Increase Risk of Breast Cancer?

PF_103332314_20

The link between pregnancy and breast cancer has been a focus of breast cancer research over the last decade, which has shown that there are a variety of factors related to pregnancy that can play a role in developing breast cancer. After a pregnancy, a woman’s short-term risk of breast cancer increases for 2-15 years, says Ann Partridge, MD, MPH, medical oncologist in the Susan F. Smith Center for Women’s Cancers, and director of the Program for Young Women with Breast Cancer. Past studies have not been able to conclude a definitive reason for this short-term increased risk. However, if a …

Continue reading

Common Myths About the HPV Vaccine

SOG_0806_09

When it comes to vaccines, particularly the HPV vaccine, it can be hard to separate fact from fiction. The Centers for Disease Control and Prevention recommends that girls and boys aged 11 or 12 years be vaccinated against HPV, the human papillomavirus, which can be spread during sexual activity and can cause cervical cancer in women and cancers of the genital and throat regions in both sexes. The two available HPV vaccines – Cervarix and Gardasil – protect against most of the cancers caused by HPV infection (Gardasil is approved for males and females). Here are some common myths and …

Continue reading

A Teen’s Journey: Developing a Diagnostic Test for Pancreatic Cancer

Jack Andraka

This post was originally written and published on Vector, Boston Children’s Hospital’s science and clinical innovation blog.  At age 13, Jack Andraka lost a family friend to pancreatic cancer. At age 15, he developed a diagnostic test for pancreatic cancer that early findings suggest is highly accurate. In this session from Boston Children’s Hospital’s Global Pediatric Innovation Summit + Awards 2014, Andraka describes his journey, the Johns Hopkins professor who took him on, his fascination with carbon nanotubes and how open access to scientific journals can help people around the world create solutions to problems. The diagnostic itself is in the early phases of testing. …

Continue reading